Skye Bioscience, Inc.
SKYENASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $61.13M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.57$7.04
- Volume (live)
- -
- Avg. volume (3M)
- 48.86K
Skye Bioscience (SKYE) Stock Price & Financial Analysis
Skye Bioscience Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.51 - $1.62 |
|---|---|
| 52-Week High | $7.04 |
| 52-Week Low | $0.57 |
| Open | $1.57 |
| Volume (last close) | 12.66K |
| Average Volume (3M) | 48.86K |
| 50-Day MA | $2.05 |
|---|---|
| 200-Day MA | $2.33 |
| 1-Year Change | +11.72% |
| Market Cap | 61.13M |
|---|---|
| Shares Outstanding | 39.69M |
| Price to Book (P/B) | -122.92 |
| EV/EBITDA | -1.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Skye Bioscience at a Glance
As of the Oct 23, 2026 close, Skye Bioscience (SKYE) has a market capitalization of $61.13M.
As of its latest reported balance sheet, it holds $8.07M in cash and securities against $143.05K of debt, a net cash position of $7.93M.
Skye Bioscience does not currently pay a dividend.
The share price is up 11.7% over the past year. At $1.54 (the Oct 23, 2026 close) it sits within its 52-week range of $0.57 to $7.04, below its 200-day moving average of $2.33.
Frequently Asked Questions About Skye Bioscience
What is the current stock price for SKYE?
As of the Oct 23, 2026 close, SKYE stock trades at $1.54. The 52-week range is $0.57–$7.04, with a day range of $1.51–$1.62.
What is the P/E ratio for SKYE?
The P/E ratio (Price-to-Earnings) for SKYE is shown in the Key Statistics section. This valuation metric helps compare Skye Bioscience, Inc. to industry peers.
Does SKYE pay dividends?
Skye Bioscience does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for SKYE?
Analyst ratings and recommendations for SKYE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of SKYE?
As of the Oct 23, 2026 close, Skye Bioscience's market capitalization is $61.1M, classifying it as a micro-cap company. Skye Bioscience operates in the Healthcare sector within the Biotechnology industry.